Home › Funds › Atle Fund Management AB › JNJ

Atle Fund Management AB position in JNJ

JOHNSON & JOHNSON · Health Care

Atle Fund Management AB reported holding 91,387 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$24.2M, representing 6.48% of its reported portfolio and ranking #3 among its reported holdings. Atle Fund Management AB has disclosed JNJ holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)91.39K sh
Reported value held$24.19M
Portfolio Weight6.48%
First reportedQ1 2026
Last changeAdd
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Atle Fund Management AB's JNJ position evolved

Atle Fund Management AB first disclosed a stake in JNJ in Q1 2026 at 92,377 shares (US$11.9M). The position peaked in Q3 2026 at 91,387 shares, worth US$24.2M. Across 3 filings, Atle Fund Management AB increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 91,387 shares valued at US$24.2M — an increase of 5,962 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 92.38K $11.94M New
Q2 2026 85.42K $21.70M Reduce
Q3 2026 91.39K $24.19M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Atle Fund Management AB held JNJ?

Atle Fund Management AB has disclosed JNJ holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Atle Fund Management AB's current position in JNJ?

As of Q3 2026, Atle Fund Management AB holds 91.39K shares of JNJ (JOHNSON & JOHNSON), valued at $24.19M, representing 6.48% of its reported portfolio and ranking #3.

Has Atle Fund Management AB been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Atle Fund Management AB increased its position in JNJ. The position peaked in Q3 2026 at 91.39K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.